Lotti Antonio, Barilaro Alessandro, Mariottini Alice, Vannozzi Lorenzo, Piergentili Marco, Fainardi Enrico, Massacesi Luca
Department of Neurosciences, Drug and Child Health, University of Florence, Florence, Italy.
Department of Neurology 2, Careggi University Hospital, Florence, Italy.
Front Neurol. 2023 Aug 11;14:1201643. doi: 10.3389/fneur.2023.1201643. eCollection 2023.
Susac syndrome (SS) is a rare immune-mediated vasculitis affecting retina, inner ear and brain. Assessment of central nervous system (CNS) involvement is currently based on standard brain magnetic resonance imaging (MRI) sequences. Accuracy of three dimensional (3D)-vessel wall imaging (VWI) was compared to standard sequences and contrast-enhanced-3D T2-fluid attenuated inversion recovery (CE-FLAIR) to assess CNS disease activity in two cases of definite SS.
Brain MRI scan and retinal fluorescein angiogram (RFA) were performed at disease onset and at 1, 3, and 6 months after induction therapy start. CE-FLAIR and VWI based on 3D black-blood proton density weighted (PDW) with and without gadolinium were added to standard sequences on a 3 Tesla MRI scanner.
Contrast enhanced-VWI (CE-VWI) detected an abnormal diffuse leptomeningeal enhancement (LME) in both cases at onset and during follow-up. Pathological enhancement on CE-VWI persisted at 6-month brain MRI, despite absence of new lesions and disappearance of LME on CE-FLAIR. Follow-up RFA revealed new arterial wall hyperfluorescence in both cases.
VWI may represent a useful tool for diagnosing and monitoring CNS disease activity in SS patients, as confirmed by concordance with RFA, leading treatment's choice and timing. Moreover, CE-VWI seemed at least as sensitive as CE-FLAIR in detecting LME, possibly being superior to the latter in posterior fossa. LME remission might be not accurate in predicting suppression of CNS inflammation in SS.
Susac综合征(SS)是一种罕见的免疫介导性血管炎,累及视网膜、内耳和脑。目前对中枢神经系统(CNS)受累情况的评估基于标准的脑磁共振成像(MRI)序列。在2例确诊的SS患者中,比较了三维(3D)血管壁成像(VWI)与标准序列及对比增强三维T2液体衰减反转恢复序列(CE-FLAIR)评估CNS疾病活动度的准确性。
在疾病发作时以及诱导治疗开始后1、3和6个月进行脑部MRI扫描和视网膜荧光血管造影(RFA)。在3特斯拉MRI扫描仪上,将基于3D黑血质子密度加权(PDW)且有无钆剂增强的CE-FLAIR和VWI添加到标准序列中。
对比增强VWI(CE-VWI)在发病时及随访期间均检测到两例患者存在异常的弥漫性软脑膜强化(LME)。尽管在6个月时脑部MRI上无新病灶且CE-FLAIR上LME消失,但CE-VWI上的病理性强化仍然存在。随访RFA显示两例患者均出现新的动脉壁高荧光。
VWI可能是诊断和监测SS患者CNS疾病活动度的有用工具,这与RFA结果一致,可指导治疗选择和时机。此外,CE-VWI在检测LME方面似乎至少与CE-FLAIR一样敏感,在后颅窝可能优于后者。LME缓解可能无法准确预测SS患者CNS炎症的抑制情况。